Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension

Lignende værker

• Phase 3 Randomized 3-Month Trial with an Ongoing 3-Month Safety Extension of Fixed-Combination Brinzolamide 1%/Brimonidine 0.2%
  af: Nguyen, Quang H., et al.
  Udgivet: (2013)
• Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies
  af: Realini, T, et al.
  Udgivet: (2013)
• Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
  af: Sharma, Sourabh, et al.
  Udgivet: (2015)
• Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus
  af: Nguyen, Quang H
  Udgivet: (2014)
• Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
  af: Gandolfi, Stefano A., et al.
  Udgivet: (2014)